TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Closed 08-26 16:00:00 EDT

0.6911

-0.0089

-1.27%

盘后0.6912

+0.0001+0.01%

19:30 EDT

High0.6996	Low0.6539	Vol61.97K
Open0.6790	D1 Closing0.7000	Amplitude6.54%
Mkt Cap30.94M	Tradable Cap14.87M	Total Shares44.77M
T/O42.21K	T/O Rate0.29%	Tradable Shares21.52M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":0.6911,"timestamp":1787774400000,"preClose":0.7,"halted":0,"volume":61970,"hourTrading":{"tag":"盘后","latestPrice":0.6912,"preClose":0.6911,"latestTime":"19:30 EDT","volume":308,"amount":212.889,"timestamp":1787787001645,"change":0.0001,"changeRate":0.000145,"amplitude":0},"delay":0,"changeRate":-0.012714285714285584,"floatShares":21519000,"shares":44765928,"eps":-0.777583,"marketStatus":"Closed","change":-0.0089,"latestTime":"08-26 16:00:00 EDT","open":0.679,"high":0.6996,"low":0.65385,"amount":42205.9983762,"amplitude":0.065357,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.777583,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":5,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":0.7,"preHourTrading":{"tag":"盘前","latestPrice":0.7,"preClose":0.7,"latestTime":"06:42 EDT","volume":30,"amount":21,"timestamp":1787740934041,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.6912,"preClose":0.6911,"latestTime":"19:30 EDT","volume":308,"amount":212.889,"timestamp":1787787001645,"change":0.0001,"changeRate":0.000145,"amplitude":0},"volumeRatio":0.125052,"impliedVol":1.6637,"impliedVolPercentile":0.5857},"requestUrl":"/m/hq/s/TELA","defaultTab":"news","newsList":[{"id":"2660747802","title":"TELA Bio CEO Heather Getz Acquires 12,500 Common Shares Valued at $8,311.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747802","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747802?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:11","pubTimestamp":1787170268,"startTime":"0","endTime":"0","summary":"TELA Bio CEO Heather Getz acquires 12,500 common shares valued at $8,311.25TELA Bio CEO Heather C. Getz bought 12,500 common shares in an open-market purchase.Shares were bought at a weighted average ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL1b5GzV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TELA Bio CEO Heather Getz Acquires 12,500 Common Shares Valued at $8,311.25","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660455081","title":"TELA Bio CEO Makes Bold Move Signaling Fresh Confidence in the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2660455081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660455081?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:02","pubTimestamp":1787018538,"startTime":"0","endTime":"0","summary":"New insider activity at TELA Bio ( ($TELA) ) has taken place on August 17, 2026. TELA Bio’s leadership is doubling down on the company’s future, as...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/tela-bio-ceo-makes-bold-move-signaling-fresh-confidence-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/tela-bio-ceo-makes-bold-move-signaling-fresh-confidence-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660616432","title":"TELA Bio CEO Heather C. Getz Acquires Common Shares Worth $10,467","url":"https://stock-news.laohu8.com/highlight/detail?id=2660616432","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660616432?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:33","pubTimestamp":1786998796,"startTime":"0","endTime":"0","summary":"TELA Bio CEO Heather C. Getz acquires common shares worth $10,467TELA Bio CEO Heather C. Getz bought 15,000 common shares at a weighted average price of 0.7.Direct holdings rose to 520,000 shares foll","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8dx6pY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TELA Bio CEO Heather C. Getz Acquires Common Shares Worth $10,467","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659028162","title":"Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume","url":"https://stock-news.laohu8.com/highlight/detail?id=2659028162","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659028162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652143,"startTime":"0","endTime":"0","summary":"Tenon Medical Q2 revenue jumps on higher surgical procedure volumeOverviewUS medical device maker's Q2 revenue rose 127% yr/yr on higher surgical procedure volumeQ2 gross profit up 232% yr/yr, gross m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","TELA","BK4539","BK4082","BK4139","XTNT","RNXT","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162446","title":"TELA Bio Amends 8-K to Detail Former CEO Koblish Separation Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162446","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162446?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651800,"startTime":"0","endTime":"0","summary":"TELA Bio amends 8-K to detail former CEO Koblish separation benefitsTELA Bio amended a prior 8-K to add details of a separation agreement with former CEO Antony Koblish, effective Aug. 7.Agreement pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL44p2Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658194362","title":"Sanara MedTech Q2 Revenue Rises on Soft-Tissue Product Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658194362","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658194362?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:20","pubTimestamp":1786479636,"startTime":"0","endTime":"0","summary":"Sanara MedTech Q2 revenue rises on soft-tissue product growthOverviewUS surgical medtech firm's Q2 revenue rose 9% yr/yr to $28.1 mlnCompany posted Q2 net loss from continuing operations, citing highe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N448105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTNT","BK4082","TCMD","BK4198","TELA","SMTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916594","title":"Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916594?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:50","pubTimestamp":1786456215,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","TELA","RCKT","LABU","BK4185","BK4198","XBI","BK4585","BK4588","HCSG","LU0029874061.USD","BK4139","BK4137","XLV","SNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992954","title":"Xtant Medical Q2 Revenue Falls on Asset Sales and Lost License Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992954","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992954?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:13","pubTimestamp":1786446795,"startTime":"0","endTime":"0","summary":"Xtant Medical Q2 revenue falls on asset sales and lost license revenueOverviewU.S. spinal and orthopedic device maker's Q2 revenue fell yr/yr, driven by asset sales and lost license revenueQ2 net loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTNT","BK4139","HRTX","BK4185","SGRY","BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994076","title":"Piper Sandler Sticks to Its Hold Rating for TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994076?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:57","pubTimestamp":1786445843,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-hold-rating-for-tela-bio-tela-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-hold-rating-for-tela-bio-tela-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658524039","title":"TELA Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658524039","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658524039?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:42","pubTimestamp":1786398159,"startTime":"0","endTime":"0","summary":"TELA Bio Inc reports results for the quarter ended June 30 - Earnings SummaryTELA Bio IncTELA.OQreported a quarterly adjusted loss of 20 cents per share for the quarter ended June 30, higher than the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383951","title":"TELA Bio Q2 Revenue Falls on Lower OviTex PRS Volumes, Withdraws Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383951","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383951?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:25","pubTimestamp":1786393554,"startTime":"0","endTime":"0","summary":"TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlookOverviewUS medical technology firm's Q2 revenue fell 4% yr/yr, missing analyst expectationsCompany withdrew full-year 2026 guida","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTRX","BK4198","BK4121","TELA","BK4185","SGRY","HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995966","title":"TELA Bio Q2 FY26 Net Loss Widens to $11.3 Million; Revenue Drops 4% to $19.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995966","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995966?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:12","pubTimestamp":1786392724,"startTime":"0","endTime":"0","summary":"TELA Bio Q2 FY26 net loss widens to $11.3 million; revenue drops 4% to $19.3 millionTELA Bio posted Q2 revenue of USD 19.3 million, down 4% year over year on weaker OviTex PRS volumes.Net loss widened","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL6MQ5cd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","NDAQ","BCDF","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD","TELA","IE00B3QW5Z07.USD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959829","title":"TELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959829","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959829?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392479,"startTime":"0","endTime":"0","summary":"TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091487/tela-bio-q2-eps-0-20-misses-0-18-estimate-sales-19-291m-miss-20-008m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959866","title":"TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959866","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959866?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392364,"startTime":"0","endTime":"0","summary":"BRIEF-TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 MillionAug 10 (Reuters) - TELA Bio Q2 net income USD -11.262 million.Q2 gross profit USD 13.943 millionQ2 income from operations USD -9.283 millionQ2 operating expenses USD 23.226 millionQ2 basic EPS USD -0.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX2F1BR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959293","title":"TELA Bio - Withdraws Full Year 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959293?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392304,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX2F1BR3:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658560659","title":"TELA Bio Q2 Basic EPS USD -0.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2658560659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658560659?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX2F1BR3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095622","title":"TELA Bio Q2 Operating Expenses USD 23.226 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095622?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392304,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX2F1BR3:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658577952","title":"TELA Bio Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658577952","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658577952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392300,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Aug.  10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3342228/0/en/tela-bio-reports-second-quarter-2026-financial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621376","title":"TELA Bio Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621376","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621376?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:53","pubTimestamp":1786139601,"startTime":"0","endTime":"0","summary":"TELA Bio Inc <TELA.OQ> expected to post a loss of18cents a share - Earnings PreviewTELA Bio IncTELA.OQTELA.Ois expected to  show a fall in quarterly revenue when it reports  results on August 10 for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442M5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520617","title":"TELA Bio CEO, Director Heather Getz Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520617?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:10","pubTimestamp":1785960605,"startTime":"0","endTime":"0","summary":"TELA Bio CEO, Director Heather Getz files initial beneficial ownership statementTELA Bio CEO Heather C. Getz filed an initial Form 3 disclosing direct ownership of 5,000 common shares as of Aug. 3.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9m5t8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":0.0886},{"period":"1month","weight":0.013},{"period":"3month","weight":-0.1945},{"period":"6month","weight":-0.1441},{"period":"1year","weight":-0.6175},{"period":"ytd","weight":-0.4068}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.1111},{"period":"1year","weight":0.1921},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.024622},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.021438},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.222765},{"month":4,"riseRate":0.285714,"avgChangeRate":0.009305},{"month":5,"riseRate":0.857143,"avgChangeRate":0.115004},{"month":6,"riseRate":0.428571,"avgChangeRate":0.019526},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.036243},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.031067},{"month":9,"riseRate":0.5,"avgChangeRate":-0.04117},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.071357},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.011933},{"month":12,"riseRate":0.571429,"avgChangeRate":0.074086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction